Insider · CIK 0001341896

Fromkin Andrew J.

Reports to the SEC for 4 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001341896

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-28	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−16.3K sh	—	—	0
2026-05-28	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+31.7K sh	$4.99	+$158K	131,400
2026-05-28	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+71.5K sh	$7.94	+$568K	202,892
2026-05-28	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+77.2K sh	$8.43	+$651K	280,073
2026-05-28	IMVTImmunovant, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+16.3K sh	$14.70	+$239K	296,333
2026-05-28	IMVTImmunovant, Inc.S Sale	Director	SSale	−11.5K sh	$32.64	−$375K	284,850
2026-05-28	IMVTImmunovant, Inc.S Sale	Director	SSale	−210K sh	$33.56	−$7.06M	74,382
2026-05-28	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−31.7K sh	—	—	0
2026-05-28	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−71.5K sh	—	—	0
2026-05-28	IMVTImmunovant, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−77.2K sh	—	—	0
2026-04-07	IMVTImmunovant, Inc.A Award	Director	AAward	+13.9K sh	—	—	99,732
2026-04-07	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,061 sh	—	—	7,061
2025-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−2,898 sh	$23.95	−$69.4K	85,852
2025-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−19.4K sh	$23.14	−$448K	88,750
2025-04-01	IMVTImmunovant, Inc.A Award	Director	AAward	+16.2K sh	—	—	108,101
2025-04-01	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,600 sh	—	—	7,600
2025-03-07	IMVTImmunovant, Inc.S Sale	Director	SSale	−1,384 sh	$19.96	−$27.6K	91,913
2025-03-07	IMVTImmunovant, Inc.S Sale	Director	SSale	−6,616 sh	$19.52	−$129K	93,297
2024-04-02	IMVTImmunovant, Inc.A Award	Director	AAward	+11.3K sh	—	—	99,913
2024-04-02	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,690 sh	—	—	4,690
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−3,941 sh	$38.78	−$153K	97,067
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−4,773 sh	$40.46	−$193K	88,658
2023-12-01	IMVTImmunovant, Inc.S Sale	Director	SSale	−3,636 sh	$39.81	−$145K	93,431
2023-04-12	IMVTImmunovant, Inc.A Award	Director	AAward	+12.5K sh	—	—	101,008
2023-04-12	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.3K sh	—	—	16,260
2022-08-17	IMVTImmunovant, Inc.A Award	Director	AAward	+21.1K sh	—	—	88,485
2022-08-17	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+31.7K sh	—	—	31,668
2022-01-10	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+71.5K sh	—	—	208,973
2022-01-10	IMVTImmunovant, Inc.A Award	Director	AAward	+21.7K sh	—	—	67,426
2021-08-10	IMVTImmunovant, Inc.P Purchase	Director	PPurchase	+5,500 sh	$7.90	+$43.5K	45,700
2021-03-19	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+23.3K sh	—	—	23,300
2021-03-19	IMVTImmunovant, Inc.A Award	Director	AAward	+15.5K sh	—	—	40,200
2020-05-15	IMVTImmunovant, Inc.A Award	Director	AAward	+24.7K sh	—	—	24,700
2020-05-15	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37K sh	—	—	37,000
2019-12-18	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director	AAward	+77.2K sh	—	—	77,181
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,666 sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−11 sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−5 sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.7K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.8K sh	—	—	0
2016-11-01	Tobira Therapeutics, Inc.Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.5K sh	—	—	0
2016-01-12	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+17.8K sh	—	—	17,778
2015-07-09	Tobira Therapeutics, Inc.Stock Options (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2015-01-01	Tobira Therapeutics, Inc.Common Stock (right to buy)A Award	Director	AAward	+159K sh	—	—	159,261
2013-11-14	Radius Health, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+2.43M sh	$3.45	+$8.37M	2,427,133
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	Director, CEO, President	DDisposition to Issuer	−110K sh	$11.61	−$1.28M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)A Award	Director, CEO, President	AAward	−110K sh	$13.46	−$1.48M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	Director, CEO, President	DDisposition to Issuer	−100K sh	$21.22	−$2.12M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	Director, CEO, President	DDisposition to Issuer	−100K sh	$13.05	−$1.31M	0
2011-04-13	CLINICAL DATA INCStock Option (right to buy)D Disposition to Issuer	Director, CEO, President	DDisposition to Issuer	−120K sh	$15.01	−$1.8M	0

Recent filings

Accepted (ET)
May 294
Fromkin Andrew J.0001341896-26-000004
SEC(opens sec.gov)
Apr 94
Fromkin Andrew J.0001764013-26-000050
SEC(opens sec.gov)
Dec 34
Fromkin Andrew J.0001764013-25-000160
SEC(opens sec.gov)
Apr 34
Fromkin Andrew J.0001764013-25-000043
SEC(opens sec.gov)
Mar 114
Fromkin Andrew J.0001764013-25-000034
SEC(opens sec.gov)
Apr 44
Fromkin Andrew J.0001764013-24-000067
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOVANT, INC. 1000 PARK FORTY PLAZA, SUITE 210

DURHAM, NC, 27713